Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Sarah Bauermeister

PhD MSc CPsychol

Senior Data & Science Manager Dementias Platform UK (DPUK)

  • DPUK Datathon lead
  • DPUK Data curation lead
  • DPUK Reach user group lead
  • DPUK multiple project PI & scientific lead
  • DPUK research supervisor
  • DPUK scientific reviewer
  • Cognitive neuropsychologist
  • Psychometric analyst

Data and Scientific Management for Dementias Platform UK (DPUK)

Cognitive Neuropsychologist - Psychometric Analyst

Sarah is a cognitive neuropsychologist managing scientific research across multiple multi-disciplinary projects, and senior Data Manager for Dementias Platform UK (DPUK) a cohort data repository for 45+ cohorts (3 million+ participants), in the research group of DPUK Director and PI, Professor John Gallacher. In DPUK she is programme lead for the DPUK Datathon intiative; programme manager for the user group DPUK Reach; project lead for DPUK Data curation; scientific lead for international DPUK collaborative AD projects; scientific reviewer for the DPUK Data Portal and represents DPUK internationally at conferences and workshops. 

As a senior researcher, she is a psychometric analyst and her research interests include applying item response theory (IRT) models to mental health, lifestyle, biomedical and healthcare scales, investigating item-level information and scale reliability. She also utilises structural equation modelling (SEM) to explore comorbidities such as cognition and mental health, child adversity and, adult biomedical outcomes and dementia. 

Dementias Platform UK    

Dementias Platform UK is a public-private partnership funded by the Medical Research Council. DPUK’s partners – ten universities and six pharmaceutical companies – have joined forces with the aim of accelerating research towards effective treatment for dementia by improving access to data. By bringing together records from over 40 different cohort studies – including brain scans, genetics and clinical records – DPUK is creating the world’s richest source of people data for use in research and drug development for dementia. This free-to-access resource of cohort data is available for use by any bona fide researcher who is interested in investigating dementia, whether based within a university or industry context. DPUK facilitates safe and secure access to this data through its Data Portal, enabling research and analyses at a scale that has not previously been possible for studies into dementia. It wishes to promote scientific research using cohort study data, and has an active programme of experimental medicine.